Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon
Thumbnail

Industry groups urge policy changes, increase in rapid response to coronavirus

As the new coronavirus, COVID-19, continues to spread across the globe and the number of infections in the U.S. rises daily, healthcare industry groups are continuing to ramp up recommendations, guidance and pressure on policymakers and regulators to ensure healthcare providers are able to respond swiftly to the crisis with flexibility.

 

Thumbnail

HHS launches emergency drug packaging solutions with public-private blend

HHS is bringing together a public-private partnership to address emergency drug packaging with a U.S.-based solution using low-cost prefilled syringes.

 

Thumbnail

Trump declares national state of emergency over coronavirus

President Trump declared a national emergency over the new coronavirus, COVID-19, on March 13, freeing up more funds to tackle the virus and respond to the crisis.

Thumbnail

Best and worst states for doctors in 2020

Montana is the best state for doctors in 2020, according to a new ranking from WalletHub.

Thumbnail

CMS outlines coverage benefits for coronavirus

CMS has issued Frequently Asked Questions to provide more information on essential health benefits coverage of the new coronavirus, COVID-19, outbreak. 

Thumbnail

Most expensive drugs in the U.S.

Drug prices in the United States are higher than anywhere else in the world, and there are some prescription medicines with price tags in the millions.

Thumbnail

Survey says: U.S. hospitals have big plans for automation

Nearly two-thirds of hospitals are hoping to implement robotic process automation and AI technologies in the next two years, according to a new survey of healthcare executives.

Thumbnail

Patients are comfortable with AI-powered cancer screening, but still want input from physicians

Patients are on board with AI-powered skin cancer screening, according to a new study published in JAMA Dermatology. But relationships with human physicians remain a priority.

Displaying 785 - 792 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup